Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.
about
Preparation of alginate coated chitosan microparticles for vaccine deliveryLipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications.Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles.Oral peptide and protein delivery: intestinal obstacles and commercial prospects.PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin.Folic acid functionalized nanoparticles for enhanced oral drug delivery.The Next Generation Non-competitive Active Polyester Nanosystems for Transferrin Receptor-mediated Peroral Transport Utilizing Gambogic Acid as a LigandDevelopment and stability studies of novel liposomal vancomycin formulations.Underestimation of rat serum vancomycin concentrations measured by an enzyme-multiplied immunoassay technique and the strategy for its avoidance.Oral bioavailability enhancement of a hydrophilic drug delivered via folic acid-coupled liposomes in rats.Preparation of DRV Liposomes.Doxorubicin-loaded liposomes: enhancing the oral bioavailability by modulation of physicochemical characteristics.Advances in Aquaculture Vaccines Against Fish Pathogens: Global Status and Current Trends
P2860
Q33385532-DEA8B6DA-1683-4971-BB8B-D74612E4B20EQ37826428-244115C9-7B61-4F91-BE8B-64A70500B458Q38177370-AEA5D331-ABE3-4447-AFA4-906AA2A51AD7Q38210847-D85C1CB9-99E5-4618-BF21-0664065FF7A5Q38627072-4323A631-1D00-4926-9728-10512BC9C1AFQ39336419-9DBF08BB-0A81-4612-92E4-47057EEC8222Q41843707-076C9E10-24EE-4F1F-8E35-A1BCBABAB8BFQ41915895-B3CA2582-3FFE-4640-8469-A5CA569263AFQ44848833-D8EBEA42-2F17-4732-AD06-B502DAF392D7Q46082629-983E582E-64D0-4E2E-B8A5-D1DBAE840F5BQ47992635-20EF88CE-54FF-4BF4-9D95-8A7F4505618DQ53329400-DCFFBF83-3E41-41BA-BA87-2F80D398C269Q56425997-18BB6B8D-6AE3-4861-930F-FF3CF9FD339C
P2860
Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Formulation and evaluation of ...... comycin liposomal dosage form.
@en
Formulation and evaluation of ...... comycin liposomal dosage form.
@nl
type
label
Formulation and evaluation of ...... comycin liposomal dosage form.
@en
Formulation and evaluation of ...... comycin liposomal dosage form.
@nl
prefLabel
Formulation and evaluation of ...... comycin liposomal dosage form.
@en
Formulation and evaluation of ...... comycin liposomal dosage form.
@nl
P2093
P356
P1476
Formulation and evaluation of ...... comycin liposomal dosage form.
@en
P2093
B R Stevenson
J A Rogers
K E Anderson
P304
P356
10.1023/A:1011002913601
P577
2001-03-01T00:00:00Z